Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Nebulized Verapamil on Oxygenation in Chronic Obstructive Pulmonary Disease (COPD) Exacerbation Patients

NCT07866989 is registered in ClinicalTrials.gov with Ain Shams University as lead sponsor.

NCT NCT07866989
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07866989 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Nebulized Verapamil on Oxygenation in Chronic Obstructive Pulmonary Disease (COPD) Exacerbation Patients
Lead sponsor
Ain Shams University
Phase
Not applicable
Overall status
Completed
Start date
April 30, 2023
Completion date
March 30, 2024
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute exacerbation of chronic obstructive pulmonary disease, chronic obstructive pulmonary disease